Advances in pancreatic cancer

Edward Kim, Diane M. Simeone

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Purpose of Review: This review intends to describe recent studies on the interaction between pancreatic cancer cells and tumor stroma, and potential opportunities and limitations to therapeutically targeting the stroma. Recent Findings: Pancreatic cancer is characterized by densely desmoplastic stroma. It is becoming increasingly clear that there are complex and mutually supportive interactions between cancer cells and the stroma. Specific signaling pathways exist between cancer cells and cancer-associated fibroblasts that contribute to hypoxic desmoplasia. Recent developments in therapeutic approaches to targeting the stroma have demonstrated potential for enhancing efficacy of cytotoxic therapies. However, the heterogeneity and genomic complexity between tumors has also become more evident based on recent findings. There is increasing evidence for hierarchy of cancer cells with identification of a subpopulation of cancer stem cells that are inherently resistant to traditional therapies. Summary: Targeting pancreatic cancer stroma is a novel therapeutic strategy that appears justified based on recent studies; however, continued focus is needed to develop more effective therapies against cells resistant to standard chemotherapy.

Original languageEnglish (US)
Pages (from-to)460-466
Number of pages7
JournalCurrent Opinion in Gastroenterology
Volume27
Issue number5
DOIs
StatePublished - Sep 2011
Externally publishedYes

Fingerprint

Pancreatic Neoplasms
Neoplasms
Neoplastic Stem Cells
Therapeutics
Cell- and Tissue-Based Therapy
Drug Therapy

Keywords

  • cancer stem cells
  • cancer-associated fibroblasts
  • pancreatic cancer
  • stroma

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Advances in pancreatic cancer. / Kim, Edward; Simeone, Diane M.

In: Current Opinion in Gastroenterology, Vol. 27, No. 5, 09.2011, p. 460-466.

Research output: Contribution to journalArticle

Kim, Edward ; Simeone, Diane M. / Advances in pancreatic cancer. In: Current Opinion in Gastroenterology. 2011 ; Vol. 27, No. 5. pp. 460-466.
@article{39252fd3f17d4fa2bfc81ec6fd6437e2,
title = "Advances in pancreatic cancer",
abstract = "Purpose of Review: This review intends to describe recent studies on the interaction between pancreatic cancer cells and tumor stroma, and potential opportunities and limitations to therapeutically targeting the stroma. Recent Findings: Pancreatic cancer is characterized by densely desmoplastic stroma. It is becoming increasingly clear that there are complex and mutually supportive interactions between cancer cells and the stroma. Specific signaling pathways exist between cancer cells and cancer-associated fibroblasts that contribute to hypoxic desmoplasia. Recent developments in therapeutic approaches to targeting the stroma have demonstrated potential for enhancing efficacy of cytotoxic therapies. However, the heterogeneity and genomic complexity between tumors has also become more evident based on recent findings. There is increasing evidence for hierarchy of cancer cells with identification of a subpopulation of cancer stem cells that are inherently resistant to traditional therapies. Summary: Targeting pancreatic cancer stroma is a novel therapeutic strategy that appears justified based on recent studies; however, continued focus is needed to develop more effective therapies against cells resistant to standard chemotherapy.",
keywords = "cancer stem cells, cancer-associated fibroblasts, pancreatic cancer, stroma",
author = "Edward Kim and Simeone, {Diane M.}",
year = "2011",
month = "9",
doi = "10.1097/MOG.0b013e328349e31f",
language = "English (US)",
volume = "27",
pages = "460--466",
journal = "Current Opinion in Gastroenterology",
issn = "0267-1379",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Advances in pancreatic cancer

AU - Kim, Edward

AU - Simeone, Diane M.

PY - 2011/9

Y1 - 2011/9

N2 - Purpose of Review: This review intends to describe recent studies on the interaction between pancreatic cancer cells and tumor stroma, and potential opportunities and limitations to therapeutically targeting the stroma. Recent Findings: Pancreatic cancer is characterized by densely desmoplastic stroma. It is becoming increasingly clear that there are complex and mutually supportive interactions between cancer cells and the stroma. Specific signaling pathways exist between cancer cells and cancer-associated fibroblasts that contribute to hypoxic desmoplasia. Recent developments in therapeutic approaches to targeting the stroma have demonstrated potential for enhancing efficacy of cytotoxic therapies. However, the heterogeneity and genomic complexity between tumors has also become more evident based on recent findings. There is increasing evidence for hierarchy of cancer cells with identification of a subpopulation of cancer stem cells that are inherently resistant to traditional therapies. Summary: Targeting pancreatic cancer stroma is a novel therapeutic strategy that appears justified based on recent studies; however, continued focus is needed to develop more effective therapies against cells resistant to standard chemotherapy.

AB - Purpose of Review: This review intends to describe recent studies on the interaction between pancreatic cancer cells and tumor stroma, and potential opportunities and limitations to therapeutically targeting the stroma. Recent Findings: Pancreatic cancer is characterized by densely desmoplastic stroma. It is becoming increasingly clear that there are complex and mutually supportive interactions between cancer cells and the stroma. Specific signaling pathways exist between cancer cells and cancer-associated fibroblasts that contribute to hypoxic desmoplasia. Recent developments in therapeutic approaches to targeting the stroma have demonstrated potential for enhancing efficacy of cytotoxic therapies. However, the heterogeneity and genomic complexity between tumors has also become more evident based on recent findings. There is increasing evidence for hierarchy of cancer cells with identification of a subpopulation of cancer stem cells that are inherently resistant to traditional therapies. Summary: Targeting pancreatic cancer stroma is a novel therapeutic strategy that appears justified based on recent studies; however, continued focus is needed to develop more effective therapies against cells resistant to standard chemotherapy.

KW - cancer stem cells

KW - cancer-associated fibroblasts

KW - pancreatic cancer

KW - stroma

UR - http://www.scopus.com/inward/record.url?scp=80051794576&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80051794576&partnerID=8YFLogxK

U2 - 10.1097/MOG.0b013e328349e31f

DO - 10.1097/MOG.0b013e328349e31f

M3 - Article

C2 - 21778878

AN - SCOPUS:80051794576

VL - 27

SP - 460

EP - 466

JO - Current Opinion in Gastroenterology

JF - Current Opinion in Gastroenterology

SN - 0267-1379

IS - 5

ER -